| Name | Walgreens #19570 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 1024 North Ave, Burlington, Vermont 05408 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (802) 865-7822 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In a paper published in Molecular Frontiers Journal, researchers from Cambridge, Massachusetts have discovered a more effective way of eliminating airborne particles from airways using nasal calcium-rich salts called FEND, which have potential applications in the fight against Covid-19.
BiondVax Pharmaceuticals Ltd. which is developing the Universal Flu Vaccine, announced today that its patent application in Israel on the Multimeric Multi-Epitope Polypeptide Influenza Vaccines (a universal flu vaccine), was accepted.
The homeless sleep less and are more likely to have insomnia and daytime fatigue than people in the general population, findings researchers believe suggest more attention needs to be paid to improving sleep for this vulnerable population, according to a research letter published online by JAMA Internal Medicine.
A particular gene variant that could serve as a predictor for type 2 diabetes has been identified by researchers at UT Southwestern Medical Center.
The BCR-ABL gene in chronic myeloid leukemia stem cells has a tendency to quickly mutate, and this may help explain why patients are predisposed to resistance to drugs like imatinib that target that gene, according to a study in the May 2 Journal of the National Cancer Institute.
› Verified 1 days ago
| NPI Number | 1962925560 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #19570 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1024 North Ave, Burlington, VT 05408 |
| Phone Number | 802-865-7822 |
News Archive
In a paper published in Molecular Frontiers Journal, researchers from Cambridge, Massachusetts have discovered a more effective way of eliminating airborne particles from airways using nasal calcium-rich salts called FEND, which have potential applications in the fight against Covid-19.
BiondVax Pharmaceuticals Ltd. which is developing the Universal Flu Vaccine, announced today that its patent application in Israel on the Multimeric Multi-Epitope Polypeptide Influenza Vaccines (a universal flu vaccine), was accepted.
The homeless sleep less and are more likely to have insomnia and daytime fatigue than people in the general population, findings researchers believe suggest more attention needs to be paid to improving sleep for this vulnerable population, according to a research letter published online by JAMA Internal Medicine.
A particular gene variant that could serve as a predictor for type 2 diabetes has been identified by researchers at UT Southwestern Medical Center.
The BCR-ABL gene in chronic myeloid leukemia stem cells has a tendency to quickly mutate, and this may help explain why patients are predisposed to resistance to drugs like imatinib that target that gene, according to a study in the May 2 Journal of the National Cancer Institute.
› Verified 1 days ago
News Archive
In a paper published in Molecular Frontiers Journal, researchers from Cambridge, Massachusetts have discovered a more effective way of eliminating airborne particles from airways using nasal calcium-rich salts called FEND, which have potential applications in the fight against Covid-19.
BiondVax Pharmaceuticals Ltd. which is developing the Universal Flu Vaccine, announced today that its patent application in Israel on the Multimeric Multi-Epitope Polypeptide Influenza Vaccines (a universal flu vaccine), was accepted.
The homeless sleep less and are more likely to have insomnia and daytime fatigue than people in the general population, findings researchers believe suggest more attention needs to be paid to improving sleep for this vulnerable population, according to a research letter published online by JAMA Internal Medicine.
A particular gene variant that could serve as a predictor for type 2 diabetes has been identified by researchers at UT Southwestern Medical Center.
The BCR-ABL gene in chronic myeloid leukemia stem cells has a tendency to quickly mutate, and this may help explain why patients are predisposed to resistance to drugs like imatinib that target that gene, according to a study in the May 2 Journal of the National Cancer Institute.
› Verified 1 days ago
Fahc Outpatient Pharmacy Type: Pharmacy Location: 1 S Prospect St, Burlington, Vermont 05401 Phone: (802) 847-3784 | |
Cvs Pharmacy #11037 Type: Community/Retail Pharmacy Location: 35 Church St, Burlington, Vermont 05401 Phone: (802) 651-1018 | |
Hannaford Food & Drug #8161 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1127 North Ave, Burlington, Vermont 05401 Phone: (802) 862-7752 | |
Walgreens #19449 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 158 Cherry St, Burlington, Vermont 05401 Phone: (802) 862-1562 | |
Walgreens #19570 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1024 North Ave, Burlington, Vermont 05408 Phone: (802) 865-7822 |